Bakx Therapeutics
Bearsville, US · Founded 2020 · Delaware corporation
Biotech
Founders & leadership
YS
Yibing ShanDirector
PL
Phillippe Lopes-FernandesDirector
EG
Ervis GavathiotisExecutive Officer, Promoter
JE
Jessie EnglishExecutive Officer, Promoter
SK
Sree KantExecutive Officer, Director, Promoter
LW
Loren WalenskyExecutive Officer, Promoter
Reported raises · per SEC filings
Form D private placements▶$20.3MraisedSep 2021 · 3 investors · BiotechnologyRule 506(b)
▶$20.3MraisedSep 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yibing ShanDirector
- Phillippe Lopes-FernandesDirector
- Ervis GavathiotisExecutive Officer, Promoter
- Jessie EnglishExecutive Officer, Promoter
- Sree KantExecutive Officer, Director, Promoter
- Frances ToneguzzoPromoter
- Loren WalenskyExecutive Officer, Promoter
- Offering amount
- $34.3M
- Amount sold
- $20.3M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.